The FDA has accepted four proposals into its complex innovative trial design program, spanning neurology, analgesia and rheumatology. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
